期刊文献+

人促血管生成素2单链抗体对裸鼠人肝癌血管生成及肿瘤生长的作用 被引量:7

Effects of angiopoietin 2 single-chain antibody on human hepatocellular carcinoma in nude mice
原文传递
导出
摘要 目的观察促血管生成素2(An萨)单链抗体(scFv-An舀)对人肝癌血管生成及肿瘤生长的作用。方法体外培养人脐静脉内皮细胞(HUVEC),各组分别添加血管内皮生长因子(VEGF)、VEGF+Ang2、VEGF+Ang2+ScFv-Ang2,通过HUVEC增殖测定、迁移实验、小管形成实验观察ScFv-Ang2在体外对HUVEC生物学行为的影响;建立荷人肝癌细胞株MHCC97的肝原位移植瘤模型裸小鼠24只,随机分为实验组和对照组,实验组瘤内注射ScFv-Ang2(4×10^11 pfu/m1),对照组予以生理盐水,测量肿瘤大小、肺转移灶数目、癌组织CD31蛋白表达及微血管密度(MVD)计数,观察ScFv-Ang2对肝细胞癌(HCC)血管生成及肿瘤生长的作用。结果体外实验中观察到ScFv-Antg2可抑制VEGF和ArtS2诱导的HUVEC增殖、迁移及小管形成;ScFv-Ang2瘤内注射组肿瘤体积、重量、肺转移灶数目、CD31表达水平以及MVD计数均显著低于对照组(P〈0.05)。结论ScFv-Ang2在体外实验中具有抑制HUVEC形成血管的作用,体内实验中对裸鼠人肝癌具有抑制血管生成和肿瘤生长的作用。 Objective To observe the effects of single-chain antibody against human angiopoietin 2 (Ang2) on the angiogenesis and growth of hepatocellular carcinoma in nude mice. Methods Human umbilical vein endothelial cells (HUVECs) were cultured and grouped in vitro. Vascular endothelial growth factor (VEGF), VEGF and Ang2, or VEGF + Ang2 + single-chain antibody (ScFv)-Ang2 was added into each group. Methyl thiazol tetrazolium (MTr) assay, Transwell assay and Matrigel assay were used to de- tect the effects of ScFv-Ang2 on angiogenie ability in vitro. A total of 24 nude mice bearing human hepato- cellular carcinoma of MHCC97 cell line with a high metastatic potential were established and randomly di- vided into 2 groups. Experimental group accepted intratumoral injection of ScFv-Ang2, and saline injection group was set as placebo-control. Mice were sacrificed on the 21 st day, tumor size and weight and metasta- ses in lungs were measured, the expression of CD31 in tumor tissues was detected by using immunohisto- chemistry, and microvessel density (MVD) was counted. Results In vitro experiment concerning HUVECs, ScFv-Ang2 inhibited VEGF- and Ang2-induced proliferation, migration and tube formation of HUVECs. Statistical indexes including tumor weight and volume, metastases to lungs, CD31 expression and MVD counting in ScFv-Ang2 injection group were all significantly lower than in placebo-control group (P 〈 0. 05). Conclusion In addition to the inhibition of blood vessel formation of HUVECs in vitro, ScFv-Ang2 exerts significant inhibitory effect on tumor growth, anglogenesis and metastasis of human hepa- tocellular carcinoma in nude mice.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2013年第8期1642-1645,共4页 Chinese Journal of Experimental Surgery
基金 中央高校基本科研业务费专项资金资助项目(303275892)
关键词 血管生成素2 单链抗体 新生血管化 肝肿瘤 Angiopoietin 2 Single-chain antibody Neovascularization Liver tumor
  • 相关文献

参考文献3

二级参考文献32

  • 1王红玲,邓长生,林军,潘定宇,邹祖玉.促血管生成素家族在大肠腺癌中的表达及与微血管密度和临床病理特征的关系[J].中华实验外科杂志,2005,22(10):1177-1179. 被引量:6
  • 2张中林,刘志苏,孙权.血管内皮生长因子和促血管生成素及其受体Tie2在肝细胞癌发生发展中的作用[J].中华实验外科杂志,2006,23(12):1492-1494. 被引量:10
  • 3Santos-Mendoza T, Favila-Castillo L, Oltra A, Tamariz J,Labarrios F, Estrada-Parra S, Estrada-Garcia L. Thalidomide and its metabolites have no effect on human lymphocyte proliferation. Int Arch Allergy Immunol 1996; 111:13-17.
  • 4BeIo AV, Ferreira MA, Bosco AA, Machado RD, Andrade SP.Differential effects of thalidomide on angiogenesis and tumor growth in mice. Inflammation 2001; 25:91-96.
  • 5Stephens TD, Bunde CJ, Fillmore BJ. Mechanism of action in thalidomide teratogenesis. Biochem Pharmacol 2000; 59:1489-1499.
  • 6Yamaguchi R, Yano H, Nakashima Y, Ogasawara S, Higaki K,Akiba J, Hicklin DJ, Kojiro M. Expression and localization of vascular endothelial growth factor receptors in human hepatocellular carcinoma and non-HCC tissues. Oncol Rev 2000: 7: 725-729.
  • 7Shimamura T, Saito S, Morita K, Kitamura T, Morimoto M,Kiba T, Numata K, Tanaka K, Sekihara H. Detection of vascular endothelial growth factor and its receptor expression in human hepatocellular carcinoma biopsy specimens. J Gastroenterol Hepatol 2000; 15:640-646.
  • 8Poon RT, Ng IO, Lau C, Yu WC, Fan ST, Wong J. Correlation of serum basic fibroblast growth factor levels with clinicopathologic features and postoperative recurrence in hepatocellular carcinoma. Am 1 Sure 2001: 182: 298-304.
  • 9uMeierhofer C, Dunzendorfer S, Wiedermann CJ. Theoretical basis for the activty of thalidomide. BioDrugs 2001; 15:681-703.
  • 10PoweII EE, Edw~ards-Smith CJ, Hay JL, Clouston AD,Crawford DH, Shorthouse C, Purdie DM, Jonsson JR. Host genetic factors influence disease progression in chronic hepatitis C. Hepatology 2000; 31:828-833.

共引文献22

同被引文献80

  • 1ZHOU Ying-zhi,FANG Xue-qiang,LI Hao,DIAO Yu-tao,YANG Yan-fang,ZHAO De-li,WU Kan,LI Hui-qing.Role of serum angiopoietin-2 level in screening for esophageal squamous cell cancer and its precursors[J].Chinese Medical Journal,2007(14):1216-1219. 被引量:7
  • 2Maeshima Y, Colorado PC,Torre A,et al. Distinct antitumor properties of a type IV collagen domain derived from basement membrane [ J ]. J Biol Chem,2000,275(28) :21340-21348.
  • 3Espov R,Beyrakhova K,Likhvantseva ,et al. A ntiangiogenic and anti- vascular effects of a recombinant tumstatin-derived peptide in a corneal neovascularization model[J]. Biochimie,2012,96(6) :1368-1375.
  • 4Maeshima Y, Manfredi M, Reimer C, et al. Identification of the anti- angingenic site within vascular basement membrane-derived tumstatin [ J]. J Biol Chem,2001,276(18) : 15240-15248.
  • 5Singal AG, Nehra M, Adams-Huet B, et al. Detection of hepatocellular carcinoma at advanced stages among patients in the HALT-C trial: where did surveillance fail? [ J ]. Am J Gastroentero1,2012,108 ( 3 ) : 425-432.
  • 6Hayes AJ, Huang WQ, Yu J, et al. Expression and function of angio- poietin-1 in breast cancer [ J ]. Br J Cancer,2000,83 (9) : 1154-1160.
  • 7Ahmad SA, Liu WB, Septg YD, et al. The erects of angiopoietin-1 and -2 on tumor growth and angiogenesis in human colon cancer[ J]. Cancer Res ,2001,61 ( 15 ) : 1255-1259.
  • 8Beecken WD, Kramer W, Jonas D. New molecular mediators in tumor angiogenesis [ J ]. J Cell Mol Med,2000,4 (4) :262-269.
  • 9Ellis LM, Ahmad S, Fan F, et al. Angiopoietins and their role in colon cancer angiogenesis [ J ]. Oncology ,2002,16 (4 Suppl 3 ) :31-35.
  • 10Tanaka S, Sugimachi K, Yamashita Y, et al. Anpiogenic switch as a molecular target of malignant tumors [J]. J Gastroenterol, 2003,38 (Suppl 15) :93-97.

引证文献7

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部